Canada - English - Health Canada

rogar/stb inc. - penicillin g procaine - liquid - 300000unit - penicillin g procaine 300000unit - cats; cattle; dogs; horses; sheep; swine (pigs)

Ireland - English - HPRA (Health Products Regulatory Authority)

glaxosmithkline (ireland) limited - cefuroxime sodium - powder for solution for injection - 250 milligram(s) - second-generation cephalosporins; cefuroxime

Ireland - English - HPRA (Health Products Regulatory Authority)

glaxosmithkline (ireland) limited - cefuroxime sodium - powder for solution for injection - 750 milligram(s) - second-generation cephalosporins; cefuroxime

Ireland - English - HPRA (Health Products Regulatory Authority)

sandoz pharmaceuticals d.d. - cefuroxime sodium - powder for solution for injection - second-generation cephalosporins; cefuroxime

Ireland - English - HPRA (Health Products Regulatory Authority)

sandoz pharmaceuticals d.d. - cefuroxime sodium - powder for solution for injection - second-generation cephalosporins; cefuroxime

Australia - English - Department of Health (Therapeutic Goods Administration)

panpharma australia pty ltd - linezolid, quantity: 600 mg - injection, solution - excipient ingredients: glucose monohydrate; sodium citrate dihydrate; citric acid; hydrochloric acid; sodium hydroxide; water for injections - linezolid is indicated for the treatment of suspected or proven infections due to gram positive organisms resistant to multiple classes of antibiotics, including methicillin resistant staphylococcus species and vancomycin resistant enterococcus species. linezolid is active against gram-positive bacteria only. linezolid has no clinical activity against gram-negative pathogens. specific gram-negative therapy is required if a concomitant gram-negative pathogen is documented or suspected.

Australia - English - Department of Health (Therapeutic Goods Administration)

panpharma australia pty ltd - linezolid, quantity: 400 mg - injection, solution - excipient ingredients: glucose monohydrate; sodium citrate dihydrate; citric acid; hydrochloric acid; sodium hydroxide; water for injections - linezolid is indicated for the treatment of suspected or proven infections due to gram positive organisms resistant to multiple classes of antibiotics, including methicillin resistant staphylococcus species and vancomycin resistant enterococcus species. linezolid is active against gram-positive bacteria only. linezolid has no clinical activity against gram-negative pathogens. specific gram-negative therapy is required if a concomitant gram-negative pathogen is documented or suspected.

Australia - English - Department of Health (Therapeutic Goods Administration)

panpharma australia pty ltd - linezolid, quantity: 200 mg - injection, solution - excipient ingredients: glucose monohydrate; sodium citrate dihydrate; citric acid; hydrochloric acid; sodium hydroxide; water for injections - linezolid is indicated for the treatment of suspected or proven infections due to gram positive organisms resistant to multiple classes of antibiotics, including methicillin resistant staphylococcus species and vancomycin resistant enterococcus species. linezolid is active against gram-positive bacteria only. linezolid has no clinical activity against gram-negative pathogens. specific gram-negative therapy is required if a concomitant gram-negative pathogen is documented or suspected.

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - linezolid, quantity: 2 mg/ml - injection, solution - excipient ingredients: citric acid; hydrochloric acid; water for injections; sodium citrate dihydrate; glucose monohydrate; sodium hydroxide - zyvox is indicated for the treatment of suspected or proven infections due to gram positive organisms resistant to multiple classes of antibiotics, including methicillin resistant staphylococcus species and vancomycin resistant enterococcus species. zyvox (linezolid) is active against gram-positive bacteria only. linezolid has no clinical activity against gram-negative pathogens. specific gram-negative therapy is required if a concomitant gram-negative pathogen is documented or suspected.

Ireland - English - HPRA (Health Products Regulatory Authority)

vetoquinol ireland limited - cloxacillin benzathine - intramammary suspension - 600 milligram(s) - cloxacillin